Cargando…

Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations

Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of com...

Descripción completa

Detalles Bibliográficos
Autores principales: Winegarner, Andrew, Kendall, Mark C., Stephen, Mekhala, Siddiqui, Afreen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522439/
https://www.ncbi.nlm.nih.gov/pubmed/37767049
http://dx.doi.org/10.1155/2023/3873076
_version_ 1785110355312115712
author Winegarner, Andrew
Kendall, Mark C.
Stephen, Mekhala
Siddiqui, Afreen
author_facet Winegarner, Andrew
Kendall, Mark C.
Stephen, Mekhala
Siddiqui, Afreen
author_sort Winegarner, Andrew
collection PubMed
description Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of common causes of hypersensitivity such as paralytics and antibiotics; however, less common triggers of anaphylaxis need to be considered as well. Midazolam, a short acting benzodiazepine metabolized by cytochrome P450 enzymes, is considered very safe with a minimal risk profile. Previous reports have described adverse reactions to occur within seconds to minutes following the administration of midazolam. We describe a patient with no known history of asthma or allergies who underwent elective hydrocelectomy with spinal analgesia without incident until 42 minutes later at the conclusion of the procedure, when they experienced circulatory collapse necessitating immediate emergency treatment. This case emphasizes the necessity to improve knowledge and awareness of delayed hypersensitivity reactions following the administration of perioperative medications such as midazolam.
format Online
Article
Text
id pubmed-10522439
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105224392023-09-27 Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations Winegarner, Andrew Kendall, Mark C. Stephen, Mekhala Siddiqui, Afreen Case Rep Anesthesiol Case Report Anaphylaxis, a type 1 hypersensitivity reaction, is a feared but uncommon complication of medications administered in the perioperative period. The incidence of perioperative hypersensitivity reactions has been reported to range from 1 in 20,000 to 1 in 1,361. Anesthesiologists are well aware of common causes of hypersensitivity such as paralytics and antibiotics; however, less common triggers of anaphylaxis need to be considered as well. Midazolam, a short acting benzodiazepine metabolized by cytochrome P450 enzymes, is considered very safe with a minimal risk profile. Previous reports have described adverse reactions to occur within seconds to minutes following the administration of midazolam. We describe a patient with no known history of asthma or allergies who underwent elective hydrocelectomy with spinal analgesia without incident until 42 minutes later at the conclusion of the procedure, when they experienced circulatory collapse necessitating immediate emergency treatment. This case emphasizes the necessity to improve knowledge and awareness of delayed hypersensitivity reactions following the administration of perioperative medications such as midazolam. Hindawi 2023-09-19 /pmc/articles/PMC10522439/ /pubmed/37767049 http://dx.doi.org/10.1155/2023/3873076 Text en Copyright © 2023 Andrew Winegarner et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Winegarner, Andrew
Kendall, Mark C.
Stephen, Mekhala
Siddiqui, Afreen
Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title_full Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title_fullStr Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title_full_unstemmed Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title_short Delayed Anaphylactic Reaction to Midazolam in the Absence of Immediate Respiratory or Skin Manifestations
title_sort delayed anaphylactic reaction to midazolam in the absence of immediate respiratory or skin manifestations
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522439/
https://www.ncbi.nlm.nih.gov/pubmed/37767049
http://dx.doi.org/10.1155/2023/3873076
work_keys_str_mv AT winegarnerandrew delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations
AT kendallmarkc delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations
AT stephenmekhala delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations
AT siddiquiafreen delayedanaphylacticreactiontomidazolamintheabsenceofimmediaterespiratoryorskinmanifestations